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ABSTRACT
Actin and actin-associated proteins have a pivotal effect on regulated
exocytosis in secretory cells and influence pre-fusion as well as post-
fusion stages of exocytosis. Actin polymerization on secretory
granules during the post-fusion phase (formation of an actin coat) is
especially important in cells with large secretory vesicles or poorly
soluble secretions. Alveolar type II (ATII) cells secrete hydrophobic
lipo-protein surfactant, which does not easily diffuse from fused
vesicles. Previous work showed that compression of actin coat is
necessary for surfactant extrusion. Here, we investigate the role of
class 1 myosins as possible linkers between actin and membranes
during exocytosis. Live-cell microscopy showed translocation of
fluorescently labeled myosin 1b and myosin 1c to the secretory
vesicle membrane after fusion. Myosin 1c translocation was
dependent on its pleckstrin homology domain. Expression of
myosin 1b and myosin 1c constructs influenced vesicle
compression rate, whereas only the inhibition of myosin 1c reduced
exocytosis. These findings suggest that class 1myosins participate in
several stages of ATII cell exocytosis and link actin coats to the
secretory vesicle membrane to influence vesicle compression.
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INTRODUCTION
Exocytosis is a pivotal mechanism for secretion of mediators,
transmitters and components of the extracellular space. The fusion
of a secretory vesicle with the plasma membrane depends on a
conserved group of proteins, which mediate the opening of the
fusion pore (Fang and Lindau, 2014; Jahn and Fasshauer, 2012;
Rizo and Südhof, 2012). Exocytosis is also influenced by actin and
actin-associated proteins, which have inhibitory as well as
stimulating roles in the pre-fusion and post-fusion phase of
exocytosis (Eitzen, 2003; Malacombe et al., 2006; Papadopulos
et al., 2013; Porat-Shliom et al., 2013). Although cortical actin
network presents a barrier for vesicle fusion with the plasma
membrane (Giner et al., 2005), actin fibers and associated motor
proteins can facilitate vesicle transport to the site of exocytosis
(Rojo Pulido et al., 2011). In addition, recent data obtained on cells
with large secretory vesicles or poorly soluble secretions indicate
that formation of the actin coat on fused vesicles has an important
role in the post-fusion phase of exocytosis. Actin coat promotes
compensatory endocytosis in oocytes (Sokac et al., 2003), stabilizes
secretory vesicles in pancreatic acinar cells (Nemoto et al., 2004;
Thorn, 2009) and provides the force for active content extrusion in
endothelial cells (Nightingale et al., 2011, 2012), salivary gland
cells (Masedunskas et al., 2011) and ATII cells (Miklavc et al.,
2009, 2012, 2015). Several groups of myosin motor proteins
associate with actin coats and influence its compression or
organization (Masedunskas et al., 2011; Miklavc et al., 2012;
Sokac et al., 2006; Yu and Bement, 2007).
Class 1 myosins function as linkers between membranes and
actin cytoskeleton in several cellular processes. They have an N-
terminal actin- and nucleotide-binding head domain, a calmodulin-
binding neck region and a C-terminal membrane-binding tail
domain (Barylko et al., 2005; McConnell and Tyska, 2010). The tail
domain contains a pleckstrin homology (PH) domain, which
enables direct association between the myosin tail and acidic
membrane lipids such as phosphatidyl inositol (4,5)-bisphosphate
(PIP2) (Hokanson et al., 2006). Myosin 1 function is regulated by
intracellular Ca2+, which binds to calmodulin and causes its
dissociation from the neck domain (Lin et al., 2005; Manceva et al.,
2007; Swanljung-Collins and Collins, 1991; Zhu et al., 1996). Of
the eight knownmyosin 1 isoforms in vertebrates, myosin 1a, 1c and
1b (Myo1a, Myo1c and Myo1b, respectively) are the best
characterized (Greenberg and Ostap, 2013; McConnell and Tyska,
2010). Myo1a is expressed only in enterocytes, where it links actin
bundles to the plasma membrane of brush border microvilli
(Crawley et al., 2014). Myo1c influences numerous cellular
processes, reaching from hair cell adaptation (Gillespie and Cyr,
2004; Stauffer et al., 2005), to regulation of gene expression
(Sarshad et al., 2013), G-actin transport during cell migration (Fan
et al., 2012) and intracellular membrane trafficking (Bose et al.,
2002, 2004; Brandstaetter et al., 2012; Chen et al., 2007; Sokac
et al., 2006). Myo1c promotes insulin-dependent exocytosis of
GLUT4-containing vesicles in muscle cells and adipocytes (Bose
et al., 2002, 2004; Chen et al., 2007) and delivery of lipid-raft-
associated proteins to the cell surface in HeLa cells (Brandstaetter
et al., 2012). In Xenopus oocytes, Myo1c links the actin coat to
fused cortical granules and transduces force generated by the actin
coat to compress the vesicle membrane (Sokac et al., 2006). In
contrast, Myo1b colocalizes with endosomes (Raposo et al., 1999;
Salas-Cortes et al., 2005) as well as with the plasma membrane
(Komaba and Coluccio, 2010) and plays a role in generation of
tubules from the Golgi network (Almeida et al., 2011; Coudrier and
Almeida, 2011) and in ephrin signaling (Prospéri et al., 2015).
Although Myo1c and Myo1b share structural similarities, their
biophysical properties differ. Myo1c can generate force over a range
of loads and has therefore been suggested to play a role as a transport
protein (Greenberg and Ostap, 2013; Greenberg et al., 2012). In
contrast, Myo1b is extremely sensitive to load and more likely
functions as a force-sensitive anchor (Greenberg and Ostap, 2013;
Laakso et al., 2008; Shuman et al., 2014).
Here, we investigate the localization and function of Myo1b and
Myo1c during exocytosis of surfactant-containing secretory
granules (lamellar bodies) in ATII cells. Surfactant is a
hydrophobic material made of lipids and proteins, which insertsReceived 1 October 2015; Accepted 25 February 2016
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in the alveolar lining fluid to reduce surface tension and enable
inspiration (Dietl and Haller, 2005; Dietl et al., 2004). The
hydrophobicity of surfactant precludes simple diffusion from the
fused vesicle and recent studies have shown that actin coat formation
on fused vesicles and its compression are pivotal for surfactant
extrusion (Miklavc et al., 2012, 2015). In this study, we show that
both isoforms, Myo1c and Myo1b, translocate to fused lamellar
bodies. However, their kinetics of translocation were strikingly
different. Slow recruitment of Myo1b to the vesicle membrane was
likely due to an inhibitory effect of the motor activity in the head
domain, whereas the translocation of Myo1c depended on the intact
PH domain in the tail region. Translocation of both isoforms was
sensitive to Ca2+. Myo1c inhibition reduced exocytosis and slowed
down actin coat compression. In contrast, inactivation of the motor
domain of Myo1b enhanced the post-fusion vesicle compression.
RESULTS
Endogenous expression of Myo1 isoforms in ATII cells
To investigate the role of myosin 1 for ATII cell exocytosis, we
first measured the relative expression of myosin 1 isoforms
by performing semi-quantitative RT-PCR (Fig. 1A). Myo1c,
Myo1b and Myo1d had the highest expression rate in freshly
isolated ATII cells as well as after 2 days of culture, whereas the
lowest expression was detected for Myo1a andMyo1g. In this work,
we focus on the localization and role of Myo1b and Myo1c during
exocytosis in ATII cells as the biophysical properties of both
isoforms are well-characterized and commercial antibodies for
immunostaining experiments on rat cells are available. In addition,
Myo1c has already been described to participate in exocytosis (Bose
et al., 2002; Sokac et al., 2006). Myo1b and Myo1c could be
detected in ATII cells in western blot experiments (Fig. 1B) and on
the membrane of fused lamellar bodies in immunostaining
experiments, where the lamellar body membrane was labeled by
immunostaining of the ABCa3 lipid transporter, and fused vesicles
were differentiated from non-fused vesicles by the presence of actin
coats (phalloidin staining) (Fig. 1C).
Myo1b and Myo1c translocation to the limiting membrane of
secretory vesicles
We investigated the kinetics of Myo1b and Myo1c translocation to
fused lamellar bodies by transfecting ATII cells with either Myo1b–
GFP or Myo1c–GFP. The time point of lamellar body fusion was
determined with LysoTracker Blue (LTB), which accumulates in
lamellar bodies and diffuses in the extracellular space during
exocytosis, resulting in a rapid decrease of fluorescent vesicle
staining (Haller et al., 1998; Miklavc et al., 2012). Cells were co-
transfected with actin–DsRed to detect actin coat formation on fused
vesicles. Myo1b–GFP and Myo1c–GFP both translocated to the
lamellar body membrane after fusion (Fig. 2). Translocation of
Myo1c–GFP to the vesicle membrane was significantly faster than
the formation of the actin coat (the half-time of Myo1c–GFP
fluorescence increase on fused lamellar bodies calculated by a
one-phase association fit was 5.13±0.9 s, n=31 and the half-time of
actin polymerization was 9.90±1.26 s, n=36; P=0.003; mean±s.e.m.;
Fig. 2A,B). In contrast, Myo1b–GFP translocation to the fused
vesicles was significantly slower than actin coat formation (the half-
time of Myo1b–GFP fluorescence increase on fused lamellar bodies
was 27.65±3.14 s, n=23; P<0.0001; Fig. 2C,D).
Fig. 1. Expression and localization of Myo1b and Myo1c
in ATII cells. (A) Semi-quantitative RT-PCR showed that
Myo1b and Myo1c are among the highest expressed Myo1
isoforms in ATII cells. Data (mean±s.e.m.) obtained from
three cell isolations and three experiments per isolation are
shown relative to the expression of the housekeeping gene
HMBS. Day 0, freshly isolated cells; Day 2, after 2 days in
culture. (B) Western blot of Myo1b and Myo1c from freshly
isolated ATII cells and ATII cells after 2 days of culture (0 and
2, respectively) to demonstrate expression of Myo1b and
Myo1c in ATII cells. Ponceau S staining was used to control
for equal protein loading (M, marker). (C) Colocalization of
anti Myo1b and Myo1c staining with fused secretory
vesicles marked by ABCa3 and phalloidin immunostaining.
The ABCa3 transporter is a marker for secretory vesicle
membrane in ATII cells. After ATP stimulation, some
vesicles fused with the plasma membrane and acquired an
actin coat, which was labeled by phalloidin staining (arrow).
Scale bars: 10 µm. Insets show the enlarged view of the
fused lamellar bodies. Scale bars: 1 µm.
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To investigate the reasons for the striking difference in the
translocation kinetics of Myo1c and Myo1b, we transfected the cells
with GFP-coupled constructs containing only the membrane-binding
tail domains of Myo1b or Myo1c (Fig. 3A). Because the expression
levels could influence the translocation kinetics, we compared
the GFP fluorescence intensity of cells expressing different
Myo1 constructs by performing either fluorescence microscopy
measurement on single cells or a plate reader assay. There was
no significant difference in GFP fluorescence between the Myo1c
or Myo1b wild-type (wt) and tail constructs (Fig. S1). The half-
time of Myo1c-tail–GFP translocation to the vesicle membrane
(5.11±0.49 s, n=24; mean±s.e.m.) was not significantly different
from that of full-length Myo1c, suggesting that the fast translocation
of the full-lengthMyo1c reflects the association of its tail domainwith
the vesicle membrane. In contrast, the half-time of Myo1b-tail–GFP
fluorescence increase (8.67±2.27 s, n=14) was significantly shorter
compared to the full-length Myo1b–GFP (P<0.0001) and not
significantly different from Myo1c–GFP or Myo1c-tail–GFP. This
observation indicates that the head domain might be responsible for
the slow translocation of full-length Myo1b to fused vesicles. To
investigate whether the slow translocation was due to the motor
activity of the Myo1b head domain, we inserted a R165A mutation
into Myo1b to block ATP hydrolysis and inactivate Myo1b motor
activity (Komaba and Coluccio, 2010; Shimada et al., 1997). The
Myo1b-R165A–GFPmutant translocated to the fused lamellar bodies
significantly faster than full-length Myo1b–GFP (Fig. 3B). The half-
time ofMyo1b-R165A–GFP fluorescence intensity increase on fused
lamellar bodies (3.98±0.71 s; n=10)was significantly shorter than the
half-time of wt Myo1b–GFP translocation (P<0.0001, Mann–
Whitney test; Fig. 3B) and not significantly different from that of
the Myo1b-tail–GFP. Myo1b R165A translocation was mostly
transient and only detectable on 75% of fused vesicles (n=24;
Fig. 3B), in contrast to wt Myo1b–GFP, which was recruited to
vesicle membrane in all observed fusion events.
Both Myo1 isoforms, 1b and 1c, have been described to contain a
PIP2-binding PH domain in their tail region (Hokanson et al., 2006;
Komaba and Coluccio, 2010), therefore we investigated the
possibility that Myo1b and Myo1c were recruited to fused
lamellar bodies through PIP2 in the lamellar body membrane. To
image PIP2 localization in living cells we used a GFP-labeled PH
domain of phospholipase Cδ (Czech, 2000; Várnai and Balla,
2007). PH-GFP was rapidly recruited to the lamellar body
Fig. 2. Translocation of Myo1b–GFPandMyo1c–GFP to fused secretory vesicles. (A) ATII cells were co-transfected with Myo1c–GFPand actin–DsRed and
stained with LTB. Myo1c–GFP translocated to secretory vesicles after fusion. Arrowheads indicate fusing vesicles and time=0 indicates the last frame before
fusion. Scale bar: 10 µm. The time of fusion pore opening was determined by LTB fluorescence decrease (upper row). Insets show an enlarged view of the fused
vesicle. Scale bar: 1 µm. (B) Mean±s.e.m. of the Myo1c–GFPand actin–DsRed fluorescence change on fusing lamellar bodies (n=31). Myo1c–GFP translocated
to fused vesicles before actin polymerization. The dashed line indicates the last frame before the fusion pore opening, determined by LTB fluorescence decrease.
(C) ATII cells were co-transfected with Myo1b–GFP and actin–DsRed and stained with LTB. Myo1b–GFP translocated to secretory vesicles after fusion.
Arrowheads point at fusing lamellar bodies and time=0 indicates the last frame before the fusion pore opening. Scale bar: 10 µm. The time of fusion pore opening
was determined by LTB fluorescence decrease (upper row). Insets show an enlarged view of one fusing vesicle. Scale bar: 1 µm. (D) Mean±s.e.m. of the Myo1b–
GFPand actin–DsRed fluorescence change on the fusing lamellar bodies (n=42). The kinetics of Myo1b–GFP translocation was slower than actin polymerization
and also slower than Myo1c translocation (B). The dashed line indicates the last frame before the fusion pore opening.
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Fig. 3. See next page for legend.
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membrane after fusion (half-time 3.65±0.49 s, n=22; Fig. 3C)
indicating that PIP2 was either translocated to or formed on the fused
lamellar bodies. To detect PIP2 together with Myo1b or Myo1c
during lamellar body exocytosis in the same cells, we co-transfected
the cells with PH–GFP and either Myo1c–mCherry or Myo1b–
mCherry (Fig. 3D). The half-time of PH–GFP fluorescence increase
on fused vesicles was not significantly different from that of
Myo1c–mCherry and significantly shorter than that of the Myo1b–
mCherry fluorescence increase (P<0.001). The remarkable
similarity between the translocation kinetics of PH–GFP and
Myo1c–mCherry suggests that the PH domain on the tail of Myo1c
might determine Myo1c translocation. To investigate this
possibility, we transfected ATII cells with Myo1c-K892A–GFP
and Myo1c-R903A–GFP constructs, where the mutations in the PH
domain of Myo1c tail region prevent PIP2 binding (Hokanson et al.,
2006). Both mutation-containing constructs localized to the cell
cytoplasm and did not translocate to the lamellar body membrane
after exocytosis (Fig. 3E), indicating the importance of the PH
domain for Myo1c translocation to the fused vesicles.
Irrespective of the lipids required for Myo1b–GFP and Myo1c–
GFP attachment to the vesicle membrane, these isoforms could
translocate to the vesicle membrane either by lateral diffusion from
the plasma membrane into the vesicle membrane or they could be
recruited from the cytosol. To investigate which possibility was
more likely, we compared the recruitment of Myo1b–GFP and
Myo1c–GFP to the fused vesicles with the recruitment of a GFP-
coupled Lyn-kinase membrane anchor domain. Lyn–GFP inserts
into the inner leaflet of the plasma membrane with acyl anchors and
translocates to the membrane of fused vesicles by lateral diffusion
(Fig. 3G; Miklavc et al., 2012). The half-time of wt Myo1b–GFP
translocation to the lamellar body membrane was not significantly
different from Lyn–GFP (half-time 29.29±8.25 s, n=10; mean±
s.e.m.), whereas Myo1c and Myo1c tail constructs translocated to
the vesicle membrane significantly faster than Lyn–GFP
(P<0.0001, Mann–Whitney test; Fig. 3H). To establish whether
the reason for this discrepancy lies in the different mobility of the
constructs in the plane of the plasma membrane, we performed
FRAP experiments. The half-time of fluorescence recovery for
Lyn–GFP (4.94±0.34 s, n=31) was not significantly different from
that ofMyo1c–GFP (6.22±0.75 s, n=29) orMyo1c-tail–GFP (4.28±
0.22 s, n=32), suggesting that their mobility in the plasma
membrane might be similar (Fig. 3I). In contrast, the fluorescence
recovery half-time of Myo1b–GFP (11.33±1.63 s, n=22) and
Myo1b-tail–GFP (6.7±0.41 s, n=30) were significantly longer
than that of Lyn–GFP (P<0.0001 and P=0.002, respectively;
Mann–Whitney test).
Ca2+ dependence ofMyo1b andMyo1c translocation to fused
vesicles
Changes in cytoplasmic Ca2+ concentration influence Myo1 motor
activity (Greenberg and Ostap, 2013; McConnell and Tyska, 2010)
and can also affect their binding to membranes directly (Tang et al.,
2002) or by changing membrane properties (Hokanson and Ostap,
2006). To investigate the influence of Ca2+ ions on Myo1b and
Myo1c localization during ATII cell exocytosis, we applied the
Ca2+ ionophore ionomycin or phorbol-12-myristate-13-acetate
(PMA) to cells transfected with either Myo1b–GFP or Myo1c–
GFP. Ionomycin causes a strong Ca2+ influx from the intracellular
space, whereas PMA stimulates lamellar body exocytosis by
directly activating protein kinase C and was used as control to
elicit fusions without an increase in intracellular Ca2+ concentration
(Frick et al., 2001). First, we determined whether the association of
Myo1b–GFP and Myo1c–GFP with the plasma membrane is Ca2+
dependent. We calculated the association of both constructs to the
plasma membrane as a ratio between the fluorescence intensity at
the edge of the cell and in the middle of the cell before and 300 s
after ionomycin or PMA stimulation (Fig. 4A,B) (Cai et al., 2013).
The localization of Myo1b andMyo1c to the plasma membrane was
confirmed by co-staining with membrane dye DiI (Fig. S2).
Ionomycin caused a significant decrease in the fluorescence ratio for
both myosin isoforms (from 0.55±0.02 to 0.34±0.02, n=32,
Fig. 3. Kinetics of Myo1b and Myo1c translocation to fused vesicles.
(A) The image series shows single fusing vesicles in Myo1b-tail–GFP- or
Myo1c-tail–GFP-transfected ATII cells. The Myo1b-tail–GFP and Myo1c-tail–
GFP translocated to fused secretory vesicles. Time=0 indicates the last frame
before the fusion pore opening. Scale bar: 1 µm. The graph shows the mean±
s.e.m. of the Myo1b-tail–GFP and Myo1c-tail–GFP fluorescence increase on
fused lamellar bodies (n=28 and 38, respectively). Both tail domains
translocated to the fused secretory vesicles with similar kinetics. The dashed
line indicates the last frame before the fusion pore opening. (B) Myo1b-R165A–
GFP translocated to fused vesicles with faster kinetics than Myo1b–GFP (see
Fig. 2D). The image series shows single fusing vesicle in ATII cells transfected
with Myo1b-R165A–GFP. Scale bar: 1 µm. The graphs show the mean±s.e.m.
of the Myo1b-R165A–GFP fluorescence change on the site of the fused
lamellar bodies (n=18, left) and the comparison of the half-times of Myo1b–
GFP and Myo1b-R165A–GFP fluorescence increase on fused vesicles (n=23
and 10, respectively; right). The dashed line on the graph and time=0 s on the
image series indicate the last frame before the fusion pore opening. The half-
time of Myo1b-R165A–GFP was significantly shorter compared to full-length
Myo1b–GFP. ****P<0.0001 (two-tailed Mann–Whitney test). (C) ATII cells
transfected with PH–GFP and stained with LTB. The arrowhead points at the
fusing lamellar body and the insets show an enlarged view of the fused vesicle.
PH–GFP translocated to secretory vesicles after fusion (bottom row). The time
of fusion pore opening was determined by LTB fluorescence decrease (upper
row). Time=0 indicates the last frame before the fusion pore opening. Scale
bars: 10 µm (image); 1 µm (inset). (D) Mean±s.e.m. of the PH–GFP, Myo1b–
mCherry and Myo1c–mCherry fluorescence increase on the fused lamellar
bodies (n=97, 36 and 61, respectively). The dashed line indicates the last
frame before the fusion pore opening, determined by LTB fluorescence
decrease. Note the similar kinetics of lamellar body localization in PH–GFP
and Myo1c–mCherry and the slower translocation of Myo1b–mCherry.
(E) Single fusing vesicles in ATII cells transfected with GFP-coupled Myo1c
constructs with a PH-domain mutation R903A or K892A and co-transfected
with actin–DsRed. These constructs had cytoplasmic localization and did not
translocate to fused vesicles after fusion. The GFP fluorescence (above) and
DsRed fluorescence (below) are shown for each vesicle. Time=0 indicates the
last frame before the fusion pore opening. Scale bar: 1 µm. (F) Mean±s.e.m. of
the Myo1c-K892A–GFP and Myo1c-R903A–GFP fluorescence change on the
site of the fused lamellar bodies (n=34 and 30, respectively). No translocation
of Myo1c-K892A–GFPandMyo1c-R903A–GFP to secretory vesicles could be
observed after fusion. Fusion pore opening is indicated by the dashed line.
(G) Mean±s.e.m. of the Lyn–GFP fluorescence increase on fused lamellar
bodies (n=20) and an image sequence of a single fusing vesicle in a Lyn–GFP-
transfected ATII cell. Lyn–GFP translocated to fused vesicles with relatively
slow kinetics compared to Myo1c–GFP or PH–GFP. The dashed line on the
graph and t=0 s on the image sequence indicate the last frame before the
fusion pore opening. Scale bar: 1 µm. (H) Translocation half-times of
GFP-tagged Myo1b and Myo1c constructs compared to Lyn–GFP. The
translocation of Myo1b–GFP to the membrane of fused vesicles was not
significantly different from Lyn–GFP, whereas the translocation of other tested
constructs was significantly faster (the n values are as given on the columns
and represent the number of vesicles). **P<0.01; ****P<0.0001; NS, not
significant (two-tailed Mann–Whitney test). (I) Half times of fluorescence
recovery after photobleaching for the same constructs shown on H. The
bleaching area (diameter=4 µm) was chosen on the edge of the cell and
fluorescence recovery was measured in 0.5 s intervals. The FRAP half-time of
Lyn–GFP was not significantly different from that of the Myo1c–GFP and
Myo1c-tail–GFP constructs, whereas the FRAP half-time was markedly
prolonged in Myo1b–GFP (the n values are as given on the columns and
represent the number of cells where FRAP was performed). **P<0.01;
****P<0.0001; NS, not significant (two-tailed Mann–Whitney test).
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P<0.0001 in Myo1c and from 0.8±0.06 to 0.21±0.02, n=29,
P<0.0001 in Myo1b; mean±s.e.m.), which reflected the
translocation from the plasma membrane to the cytosol upon Ca2+
elevation (Fig. 4C). PMA induced a small but significant decrease
in membrane-to-cytosol ratio in Myo1c-transfected cells (0.6±0.02
to 0.55±0.02, n=33, P=0.001), whereas the difference in Myo1b-
transfected cells was not significant (0.74±0.06 before stimulation
to 0.74±0.06 after stimulation, n=25; Fig. 4C). The significance was
calculated with the Wilcoxon matched-pairs signed rank test.
Because Ca2+ had such a profound influence onMyo1c–GFP and
Myo1b–GFP association with the plasma membrane, we tested
whether there is a difference in the post-fusion translocation of these
constructs to the vesicle membrane. We measured translocation
half-times after ionomycin or PMA stimulation, and compared
those with values after ATP stimulation, which is a physiological
stimulus for lamellar body exocytosis. In ATII cells, ATP induces a
transient general intracellular Ca2+ increase by stimulating Ca2+
release from the intracellular stores (Rooney, 2001), followed by a
local perivesicular Ca2+ increase around fused vesicles (Miklavc
et al., 2010, 2011). The half-time of Myo1c–GFP translocation to
vesicle membrane after ionomycin stimulation was 8.90±1.32 s
(n=14), which was significantly longer than after PMA stimulation
(5.10± 0.60 s, n=9; P=0.04) or after ATP stimulation (5.13±0.9 s,
n=31; P=0.02; Fig. 4D). A similar pattern was observed in Myo1b–
GFP-transfected cells, where the translocation half-time after
ionomycin stimulation (42.03±5.04 s, n=9) was significantly
longer than the half-time of translocation after PMA stimulation
(23.95±2.97 s, n=8; P=0.009) and after ATP stimulation (27.65±
3.14 s, n=23; P=0.02). The differences between ATP and PMA
stimulation were not significant for both constructs (Fig. 4D).
Myo1 influence on exocytosis in ATII cells
After we researched the possible causes for Myo1b and Myo1c
translocation to the fused lamellar bodies, wewere interested in their
Fig. 4. Ca2+ dependency of Myo1b and Myo1c translocation. (A) Myo1b–GFP-transfected ATII cells before (time=0 s) and after (300 s) stimulation with either
ionomycin (upper row) or PMA (bottom row). A change in Myo1b localization was only observed after ionomycin stimulation. Scale bar: 10 µm. (B) Myo1c–
GFP-transfected ATII cells (left) before (time=0 s) and after (300 s) stimulation with either ionomycin (upper row) or PMA (bottom row). Scale bar: 10 µm. The lines
on the right side indicate the location of the line scan measurement. Line scans were used to calculate the ratio between the fluorescence intensity of the edge
of the cell (black arrows) and the center of the cell (gray arrows), before (solid line) and 300 s after stimulation (dashed line). (C) Comparison of the fluorescence
ratio (mean±s.e.m.) between the cell membrane and the cell cytoplasm for ionomycin or PMA stimulation in ATII cells transfected with either Myo1b–GFP (left
graph) or Myo1c–GFP (right graph). The fluorescence ratio between the membrane and the cytoplasm of Myo1b–GFP and Myo1c–GFP decreased significantly
after ionomycin stimulation, whereas PMA stimulation only affected Myo1c localization. n=29 and 25 cells were transfected with Myo1b–GFP, and 32 and 33 cells
with Myo1c–GFP for ionomycin and PMA stimulation, respectively. **P<0.01, ****P<0.0001 (two-tailed Wilcoxon matched-pairs signed rank test). (D) Half-times
(mean±s.e.m.) of Myo1c–GFP and Myo1b–GFP translocation to fused vesicles after cell stimulation with either ATP, ionomycin or PMA. After ionomycin
stimulation the translocation of both myosin isoforms, Myo1b–GFP and Myo1c–GFP was significantly slower than after PMA or ATP stimulation. n=31, 14 and 9
vesicles in Myo1c–GFP-transfected cells, and 23, 9 and 8 vesicles in Myo1b–GFP-transfected cells for ATP, ionomycin and PMA stimulation, respectively.
*P<0.05; **P<0.01 (two-tailed t-test).
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function for lamellar body exocytosis. It has already been described
that inhibition of Myo1c has a negative effect on insulin-dependent
exocytosis of GLUT4-containing vesicles in adipocytes (Bose et al.,
2002, 2004) and skeletal muscle cells (Toyoda et al., 2011). We
tested the influence of Myo1c and Myo1b on exocytosis in ATII
cells by expressing the dominant-negative Myo1b tail or Myo1c tail
domain. The effect on exocytosis was determined by counting the
number of cells, which responded to ATP stimulation with at least
one fusion event (Fig. 5A). Transfection with Myo1c-tail–GFP
reduced the proportion of responding cells (1.78±0.94%, n=12
independent experiments; mean±s.e.m.) compared to untransfected
cells (5.58±0.54%, n=95 independent experiments; P=0.002), cells
transfected with the wt Myo1c–GFP (5.08±1.07%, n=26
independent experiments; P=0.04), or cells transfected with
control construct Lyn–GFP (4.21±0.92%, n=25 independent
experiments; P=0.08). In contrast, transfection with the Myo1b-
tail–GFP did not affect exocytosis (5.24±1.44%, n=11 independent
experiments). Up to four time-lapse image sequences were analyzed
for each experiment, up to 56 cells were analyzed for each image
sequence. A Mann–Whitney test was used for statistics.
In addition to genetic inhibition, we used pharmacological
inhibition with pentachloropseudilin (PClP), an allosteric inhibitor
specific for class 1 myosins (Chinthalapudi et al., 2011; Martin
et al., 2009). The percentage of ATII cells responding after 10 µM
PClP treatment (0.29±0.2%, n=12 independent experiments) was
significantly lower than the percentage of responding cells in
untreated control cells (5.49±2%, n=11 independent experiments;
P=0.0006, Mann–Whitney test; Fig. 5B). Up to four time-lapse
image sequences were analyzed for each experiment.
Myo1 coupling between actin coat and vesicle membrane
In addition to investigating the effect of dominant-negative Myo1b
tail or Myo1c tail constructs on the percentage of responding cells,
we also investigated their effect on actin coating during the post-
fusion phase of lamellar body exocytosis. Transfection with
dominant-negative Myo1b-tail–GFP or Myo1c-tail–GFP did not
inhibit actin coat formation (Fig. 6A). The half-time of the actin coat
polymerization in cells transfected with Myo1b-tail–GFP or
Myo1c-tail–GFP was not significantly different from the half-time
in cells transfected with wt Myo1b–GFP or wt Myo1c–GFP or from
cells expressing control GFP construct (Fig. 6B). In addition,
transfection with tail domains of Myo1c or Myo1b constructs had
no effect on the delay from fusion to actin coat formation (Fig. 6C).
Inhibition of Myo1 with PClP inhibitor also did not inhibit actin
coats (Fig. S3).
Because the inhibition of Myo1b and Myo1c had no obvious
effect on actin coat formation, we tested the hypothesis that the
disruption of their function as a linker between actin coat and
vesicle membrane might influence actin coat compression.
The compression of fused vesicles in cells transfected with
Myo1b-tail–GFP (measured as a decrease in vesicle diameter)
was not significantly different from compression in cells transfected
with the control construct Lyn–GFP. Vesicle compression in cells
transfected with full-length Myo1b–GFP was slower than in control
cells; however, the differences only reached significance at 45 s
after fusion (P=0.01; Fig. 6D). Interestingly, fused vesicles in cells
co-transfected with Myo1b-R165A–GFP and actin–DsRed
compressed significantly faster than vesicles in control cells,
which were transfected only with actin–DsRed (Fig. 6E). In
contrast, vesicle compression was significantly reduced in cells
transfected with the dominant-negative Myo1c tail (Fig. 6F).
Pharmacological inhibition of Myo1 with PClP had an even
stronger effect on the vesicle compression rate, as vesicles only
compressed to 89.7% of the initial vesicle diameter in PClP-treated
cells compared to 68.8% in Lyn–GFP-transfected cells (t=225 s;
Fig. 6F). In addition, we measured the compression of vesicles in
cells co-transfected with Myo1c–mCherry and PH–GFP to test for
possible inhibitory effects of PH–GFP expression due to the binding
of both constructs on PIP2. The vesicle compression in cells co-
expressing both constructs was slightly reduced compared to cells
transfected with Myo1c–mCherry alone and the differences were
significant at time points 75 and 105 s after fusion (P=0.03 and
P=0.01; Fig. 6G).
DISCUSSION
We showed previously that compression of actin coats on fused
secretory vesicles in ATII cells is necessary for surfactant extrusion
Fig. 5. The influence of Myo1c and Myo1b on exocytosis. (A) The
proportion (mean±s.e.m.) of cells responding to ATP stimulation with
exocytosis in untransfected ATII cells and in cells transfected with Lyn–GFP
control construct or Myo1b or Myo1c constructs. The percentage of cells
showing exocytosis was significantly reduced in cells transfected with Myo1c
tail-GFP compared to untransfected cells and full-length Myo1c-GFP.
Transfection with Myo1b tail-GFP did not significantly change the proportion of
cells with exocytosis. The numbers in the columns indicate the number of
independent experiments, up to four time-lapse image sequences were
analyzed for each experiment, up to 56 cells were analyzed for each image
sequence. *P<0.05; **P<0.01; NS, not significant (two-tailed Mann–Whitney
test). (B) Incubation of ATII cells with 10 µM PClP inhibitor for 2 h significantly
decreased the percentage of cells responding to ATP stimulation with
exocytosis compared to untreated cells. ***P<0.001 (two-tailed Mann–Whitney
test). The numbers in the columns indicate the number of independent
experiments, up to four time-lapse image sequences were analyzed for each
experiment, and up to 36 cells were analyzed for each image sequence.
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Fig. 6. Actin coat formation and compression in ATII cells transfected with Myo1b and Myo1c constructs. (A) ATII cells co-transfected with actin–DsRed
and Myo1b-tail–GFP (upper panel) or co-transfected with actin–DsRed and Myo1c-tail–GFP (lower panel). Myo1b-tail–GFP and Myo1c-tail–GFP
translocated to fused secretory vesicles, which became coated with actin. Time=0 indicates the last time point before fusion, arrowheads point at the fusing vesicle
and the insets show the enlarged view of fusing lamellar bodies. Scale bars: 10 µm (main images); 1 µm (insets). (B) Mean±s.e.m. of the half-time for actin
polymerization on fused vesicles in ATII cells transfected with actin-DsRed and co-transfected with GFP or GFP-tagged Myo1b or Myo1c constructs. The
numbers in the columns indicate the number of actin coats. No significant difference in the half-times for actin polymerization could be observed between cells
transfectedwith GFP control andmyosin constructs (two-tailedMann–Whitney test). (C) Mean±s.e.m. of the delay from the fusion pore opening to the start of actin
coat formation in ATII cells transfected with actin–DsRed and co-transfected with GFP-tagged Myo1b or Myo1c constructs. The numbers in the columns indicate
the number of actin coats. No significant difference of delay from fusion for actin polymerization could be observed between cells transfected with GFP control and
myosin constructs (two-tailed Mann–Whitney test). (D) Normalized vesicle diameter decrease (mean±s.e.m.) after fusion in ATII cells transfected with Lyn–GFP,
Myo1b–GFP or Myo1b-tail–GFP (n=18, 31 and 44, respectively). A slower compression rate was observed in cells transfected with full-length Myo1b–GFP
compared to Lyn–GFP. *P<0.05 (two-tailed t-test). (E) Normalized vesicle diameter decrease (mean±s.e.m.) after fusion in ATII cells transfected with
actin–DsRed (control) or co-transfected with actin–DsRed and Myo1b-R165A–GFP. Fused vesicles in cells co-transfected with actin–DsRed and
Myo1b-R165A–GFP (n=15) compressed significantly faster than control vesicles in cells transfected with actin–DsRed alone (n=16). *P<0.05, **P<0.01,
***P<0.001 (two-tailed t-test). (F) Normalized vesicle diameter decrease (mean±s.e.m.) after fusion in ATII cells transfected with Lyn–GFP, Myo1c–GFP,
Myo1c-tail–GFPor Lyn–GFP treated with 10 µMPClP (n=18, 43, 34 and 12, respectively). Fused vesicles in cells transfected with Myo1c-tail–GFPor treated with
10 µM PClP inhibitor compressed significantly slower than vesicles in cells transfected with the control construct Lyn–GFP. *P<0.05, **P<0.01, ***P<0.01,
****P<0.0001 (two-tailed t-test). (G) Normalized vesicle diameter decrease (mean±s.e.m.) after fusion in ATII cells transfected with Myo1c–mCherry (n=5) and in
cells co-transfected with Myo1c–mCherry and PH–GFP (n=29). The vesicle compression was slower in cells co-transfected with Myo1c–mCherry and PH–GFP;
however, the differences were significant only at 75 s and 105 s. *P<0.05 (two-tailed t-test).
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(Miklavc et al., 2012). The actin coat compresses the fused vesicle
by the combined action of myosin-II- and cofilin-mediated
depolymerization of actin fibers followed by α-actinin-mediated
cross-linking (Miklavc et al., 2015). Although we could identify
Rho GTPases and nucleation factors of the formin family as
initiators of actin coat polymerization on fused lamellar bodies
(Miklavc et al., 2012), the mechanisms of actin coat attachment to
the vesicle membrane are not clear. In this work, we demonstrate
that Myo1b and Myo1c translocate to the membrane of fused
secretory vesicles in ATII cells and that their inhibition influences
the compression of actin coat. In addition, inhibition of Myo1c also
reduces exocytosis in ATII cells, suggesting that the Myo1 family
can play a role in several stages of surfactant exocytosis.
Myo1 family members attach actin cytoskeleton to membranes
(Barylko et al., 2005; Coudrier and Almeida, 2011; Laakso et al.,
2008;McConnell and Tyska, 2010) and have been suggested to play
a role in several stages of secretory process (Bond et al., 2011;
Woolner and Bement, 2009). Myo1c couples the actin coat to the
membrane of fused vesicles in oocytes (Sokac et al., 2006). The
translocation of Myo1c tail domain to the fused lamellar bodies
suggests that the tail domain alone is sufficient for translocation to
fused vesicles, supporting previously published observations
(Hokanson et al., 2006; Sokac et al., 2006). Similarities in
translocation kinetics of full-length Myo1c, the Myo1c tail or PH-
PLCδ to lamellar bodies suggest that Myo1c translocation to fused
vesicles is PIP2 dependent. Mutation of the basic residues in the PH
domain (K892A and R903A), which prevent Myo1c binding to
PIP2 lipids (Hokanson et al., 2006), completely abolished
translocation of Myo1c to the lamellar body membrane after fusion.
Myo1b has been previously shown to localize to endosomal
compartments as well as to PIP2-rich membrane regions (Komaba
and Coluccio, 2010; Raposo et al., 1999; Ruppert et al., 1995) and its
association with actin coats on fused vesicles had not been previously
described. Sequence similarities between the Myo1c and Myo1b PH
domain suggested that they would have similar lipid-binding
properties (Hokanson et al., 2006). Although in ATII cells, the half-
time of Myo1b tail translocation to fused lamellar bodies was not
significantly different from the translocation of the Myo1c or Myo1c
tail domain, the translocation of full-length Myo1b to the vesicle
membrane was significantly slower. This is consistent with previous
observations (Mazerik et al., 2014), where single-molecule total
internal reflection fluorescence (TIRF) microscopy showed reduced
mobility of full-length Myo1b in the plasma membrane. FRAP
experiments in ATII cells showed slower diffusion of Myo1b in the
plane of the plasma membrane compared to Myo1c or the control
construct Lyn–GFP. In addition, the ATP-hydrolysis-deficient
Myo1b R165A mutant translocated to the fused vesicles
significantly faster than the wt Myo1b, and its translocation was
transient, suggesting that actin-binding head domain might be
involved in the retention ofMyo1b at themembrane of fused vesicles.
Full-length Myo1b translocated to the vesicle membrane with
similar kinetics to Lyn–GFP, which is inserted in the inner leaflet of
the plasma membrane by myristyl and palmityl anchors (Kovárová
et al., 2001). Although slow translocation of full-length Myo1b to
the secretory vesicles after fusion might be explained by its actin
binding, as discussed above, the equally slow translocation of Lyn–
GFP cannot be explained in this way. FRAP experiments suggest
that mobility of Lyn–GFP is comparable to the mobility of Myo1c
and Myo1c tail constructs, which is consistent with reports on fast
diffusion of Lyn–GFP in the plane of the plasma membrane
(Schmidt and Nichols, 2004). It is therefore possible that the rapid
translocation of full-length Myo1c and Myo1c tail to the fused
vesicles is due to the recruitment of Myo1 from the cytosol.
Alternatively, the fusion pore structure might represent a barrier for
lateral diffusion of membrane proteins with lipid anchors.
Cytosolic Ca2+ plays an important role for surfactant secretion.
The increase in intracellular Ca2+ concentration caused by cell
stretch or extracellular ATP are the most potent physiological stimuli
leading to lamellar body exocytosis (Dietl et al., 2010, 2012) and
can also contribute to the widening of the fusion pore (Miklavc
et al., 2011). The motor activity and membrane-binding properties
of Myo1 depend on the cytoplasmic Ca2+ concentration (Greenberg
and Ostap, 2013; McConnell and Tyska, 2010; Tang et al., 2002)
and it is therefore possible that changes in Ca2+ concentration during
exocytosis in ATII cells might influence Myo1 translocation to the
secretory vesicles as well as its function. Ca2+ binding changes the
Myo1 force generation capability (Lin et al., 2005; Swanljung-
Collins and Collins, 1991; Zhu et al., 1996) and has also been
suggested to promote membrane attachment (Cyr et al., 2002;
Swanljung-Collins and Collins, 1992). In contrast, elevation of
intracellular Ca2+ concentration by ionomycin in HEK cells caused
the translocation of the Myo1c tail domain from the plasma
membrane to the cytosol (Hokanson and Ostap, 2006). Our findings
in ATII cells also suggest that Ca2+ elevation does not promote
membrane binding. Addition of ionomycin resulted in a marked
translocation of Myo1c and Myo1b from the plasma membrane to
the cytosol. Stimulation with PMA had no effect on Myo1b
translocation. However, it caused a small but significant
translocation of Myo1c from the plasma membrane to the cytosol.
This observation might be due to the direct effect of PMA on the
decrease of PIP2 concentration on the plasma membrane (Zeng
et al., 2003), which might affect Myo1c more strongly than Myo1b.
The translocation to the membrane of fused vesicles was slower after
ionomycin stimulation compared to PMA stimulation for both the
Myo1b and Myo1c constructs. Interestingly, the translocation half-
times after ATP and PMA stimulation were not significantly
different. This might be explained by the transient Ca2+ increase
after ATP stimulation versus prolonged cell fusion response.
Myo1b and Myo1c translocated to the fused secretory vesicles
after fusion pore opening, which suggests that their main function
might be during the post-fusion phase of exocytosis. We did not find
significant differences in actin coat polymerization when we
compared half-times of actin polymerization and the delay
between fusion and the start of actin coat formation after Myo1b
orMyo1c inhibition. This suggests that Myo1b andMyo1c likely do
not play a major role in actin coat formation. However, our results
suggest that Myo1b and Myo1c might be necessary for the normal
coat compression. In oocytes, uncoupling of the actin coat from the
vesicle membrane by transfecting cells with the Myo1c tail resulted
in inhibition of coat compression (Sokac et al., 2006). We could
confirm this observation in ATII cells. Interestingly, although the
transfection of cells with the Myo1b tail had no effect on vesicle
compression, we observed a marked increase in the vesicle
compression rate after transfecting the cells with the Myo1b
R165Amutant. Conversely, overexpression of wtMyo1b resulted in
a slight decrease in vesicle compression rate. These observations
suggests that Myo1bmight play a role of a tension sensitive ‘anchor’
for the vesicle compression as suggested by biophysical properties
of Myo1b (Laakso et al., 2008, 2010). PClP, an allosteric inhibitor
that reversibly binds near the actin-binding region on the myosin
motor domain has been shown to be specific for Myo1 family, and
inhibits Myo1c as well as Myo1b (Chinthalapudi et al., 2011;
Martin et al., 2009). We observed that PC1P treatment decreased the
rate of vesicle compression without affecting actin coat formation,
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similar to genetic inhibition of Myo1c. This might be due to a higher
expression ofMyo1c in ATII cells or to a more notable physiological
role of Myo1c in actin coat compression as compared to Myo1b. A
similar observation was made in HeLa cells, where PClP inhibition
resulted in identical changes in lysosomal morphology as described
for the small interfering RNA (siRNA)-mediated knockdown of
Myo1c (Chinthalapudi et al., 2011).
Myo1c was not only reported to connect the actin coat to the
membrane of fusing vesicles but also to facilitate vesicle fusion with
the plasma membrane. In adipocytes and skeletal muscle cells,
Myo1c inhibition leads to a decreased exocytosis of GLUT4-
containing vesicles after insulin stimulation (Bose et al., 2002,
2004; Toyoda et al., 2011) and in HeLa cells to decreased
incorporation of GPI-linked proteins in the plasma membrane
(Brandstaetter et al., 2012). TIRF experiments showed that Myo1c
tethers GLUT4 vesicles to the plasma membrane and the absence of
this tethering inhibits exocytosis (Boguslavsky et al., 2012). It is not
yet clear whether Myo1c promotes lamellar body exocytosis in ATII
cells through the same tethering mechanism. However, it is more
likely that the function of Myo1c is in cortical actin rearrangement
or lamellar body tethering to the plasma membrane than in active
vesicular transport. Although a proteomics study on isolated
lamellar bodies has suggested that there are Myo1c as well as
Myo1b molecules associated with lamellar bodies (Ridsdale et al.,
2011), we could observe a strong translocation of Myo1c and
Myo1b to lamellar body membrane only after fusion, whereas their
presence on non-fused lamellar bodies was not detectable by
conventional fluorescence microscopy.
Together, these data indicate that Myo1c and Myo1b translocate
to secretory vesicles in ATII cells after fusion. The translocation of
Myo1c to the vesicle membrane closely resembled the translocation
of PH-PLCδ, whereas the translocation of Myo1b was markedly
slower. The inhibition of Myo1c reduced secretory vesicle
exocytosis and slowed down actin coat compression. In contrast,
Myo1b R165A induced an increase in actin coat compression rate,
suggesting that several mechanisms are necessary for efficient actin
coat compression.
MATERIALS AND METHODS
Cell isolation and transfection
ATII cells were isolated from the lungs of male Sprague-Dawley rats, aged
3–4 months, according to the procedure of Dobbs et al. (1986) and cultured
as recently described (Miklavc et al., 2010). Rats were kept at the central
animal facility of the Ulm University according to guidelines for ethical care
of animals. All experiments in this study were approved by the
Regierungspräsidium Tübingen, Germany. Isolated cells were used for
experiments for up to 48 h after isolation because longer cell culture times
result in rapid loss of ATII cell characteristics (Diglio and Kikkawa, 1977;
Mason and Dobbs, 1980). ATII cells were transfected by electroporation or
by adenoviral vectors as recently described (Miklavc et al., 2015).
Plasmids and adenoviral vectors
Plasmids expressing Myo1c–GFP, Myo1c-tail–GFP, Myo1c-R903A–
GFP and Myo1c-K892A–GFP were a kind gift from E. Michael Ostap
(University of Pennsylvania, Philadelphia, USA) (Hokanson et al.,
2006); Myo1b–GFP and Myo1b-tail–GFP were generously provided by
Evelyn Coudrier (Institut Curie, Paris, France) (Raposo et al., 1999) and
PH-GFP adenovirus was kindly provided by Ora Weisz (University of
Pittsburgh, Pittsburgh, USA) (Weixel et al., 2007). Myo1b-R165A–GFP
was created with the Infusion system (Clontech, TakaraBio, France).
Myo1c–mCherry was made by cloning PCR-amplified mCherry from the
pmCherry-N1 vector (Clontech, TakaraBio, France) in Myo1c–GFP
using AgeI and NotI restriction sites. Myo1b–mCherry was made by
cloning PCR-amplified mCherry from pmCherry-N1 vector (Clontech,
TakaraBio, France) in Myo1b–GFP using NheI and XhoI restriction sites.
Adenoviruses expressing actin–GFP and actin–DsRed and plasmid for
Lyn–GFP were recently described (Frick et al., 2007; Miklavc et al.,
2009, 2012). As control GFP plasmid we used pmax GFP™ (Lonza,
Germany).
Experimental conditions
For all experiments, ATII cells were kept in bath solution (in mM: 140 NaCl,
5 KCl, 1 MgCl2, 2 CaCl2, 5 glucose, 10 Hepes; pH 7.4). Cells were
stimulated for secretion with 100 μM ATP (Sigma, Schnelldorf, Germany),
300 nM PMA, or 3 µM ionomycin. Fusions were detected with LysoTracker
Red (10 nM, 10 min incubation) or LysoTracker Blue (100 nM, 20 min)
(Haller et al., 1998). For pharmacological inhibition of Myo1, ATII cells
were preincubated with 10 µM PClP inhibitor for 2 h. Fluorescent dyes were
purchased from Molecular Probes (Life Technologies, Darmstadt,
Germany).
Semi-quantitative RT-PCR
Semi-quantitative RT-PCR was performed on 0.8–1.3 µg RNA with
SuperScript VILO synthesis kit and QuantiTect primer assays (Quiagen,
Hilden, Germany) on a realplex2 mastercycler (Eppendorf, Hamburg,
Germany) as described in detail previously (Miklavc et al., 2015).
Western blot analysis
Western blot was performed on freshly isolated ATII cells or ATII cells after
2 days of culture as described in detail previously (Miklavc et al., 2011).
Primary antibody against Myo1c purchased fromAbcam (catalogue number
ab51261, lot number GR150630-3; Cambridge, UK) and primary antibody
against Myo1b purchased from Novus biologicals (catalogue number
NBP1-87739, lot number A39461; Littleton, USA) were used in
concentrations suggested by the manufacturer (1:1000 for Myo1c and
1:500 for Myo1b). The manufacturer verified antibody specificity.
Immunofluorescence
Primary antibody against ABCa3 was purchased from Abcam (catalogue
number ab24751, lot number GR133811-2). Fluorescently labeled
secondary antibodies and Alexa-Fluor-568-conjugated phalloidin were
purchased from Molecular Probes (Life Technologies, Darmstadt,
Germany). We used primary antibody dilutions suggested by the
manufacturer (1:50 for anti-Myo1b and -Myo1c antibodies, 1:300 for
anti-ABCa3 antibody). Images were taken on Leica TCS SP5 confocal
microscope (Leica, Wetzlar, Germany) using a 63× objective (Leica
HCX PL APO lambda blue 63.0×1.40 OIL UV). Images for the green
(Alexa Fluor 488), red (Alexa Fluor 568) and far red (Alexa Fluor 647)
channels were taken sequentially using appropriate excitation and
emission settings.
Fluorescence imaging
Fluorescence imaging experiments on living cells were performed on an
iMic digital microscope (Till Photonics, Gräfelfing, Germany) as described
previously (Miklavc et al., 2015). FRAP experiments were performed on an
iMic microscope using a green laser at 95% intensity to bleach a circular
region of interest (diameter=4 µm). DiI-stained cells were imaged on a Cell
Observer microscope (Visitron, Puchheim, Germany) with 40× oil
immersion objective and MetaMorph acquisition software (Molecular
Devices, Sunnyvale, USA).
Image analysis and data presentation
Images were analyzed using Fiji (NIH, Bethesda, USA). GraphPad Prism 5
(GraphPad Software, La Jolla, USA) was used for curve fitting and graph
design. Lamellar body compression after fusion was analyzed by measuring
the vesicle perimeter at indicated time points after fusion. A circular region
of interest was set around the fusing lamellar body to determine the onset of
lamellar body fusion by measuring LysoTracker fluorescence or to measure
the translocation of fluorescently labeled constructs (Miklavc et al., 2012,
2015). Figures were prepared with Adobe Photoshop CS2 (Adobe, San Jose,
USA).
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Statistical analysis
We used Excel (Microsoft, Redmond, USA) and GraphPad Prism 5
(GraphPad Software, La Jolla, USA) for statistical analysis. Unless stated
otherwise, n indicates the number of fused vesicles where fluorescence
changes were measured and was set to ≥5. The fusions were recorded in
4–21 independent experiments on ATII cells from 2–7 cell isolations. Only
vesicles where the fluorescence signal to noise ratio was sufficiently high
and where the whole secretory process could be monitored were used for
analysis (predefined). Unless stated otherwise data are presented as mean,
the s.e.m. was used to estimate the variation within data groups (indicated
for every data set) and two tailed t-test was used for statistical comparison.
The D’Agostino and Pearson omnibus normality test was used to estimate
the data distribution.
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